Article Versions Notes

Gowrikumar S, Primeaux M, Pravoverov K, Wu C, Szeglin BC, Sauvé C-EG, Thapa I, Bastola D, Chen XS, Smith JJ, et al. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients. Cells. 2021; 10(9):2211. https://doi.org/10.3390/cells10092211

Gowrikumar, Saiprasad, Mark Primeaux, Kristina Pravoverov, Chao Wu, Bryan C. Szeglin, Charles-Etienne Gabriel Sauvé, Ishwor Thapa, Dhundy Bastola, Xi Steven Chen, J. Joshua Smith, and et al. 2021. "A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients" Cells 10, no. 9: 2211. https://doi.org/10.3390/cells10092211

Gowrikumar, S., Primeaux, M., Pravoverov, K., Wu, C., Szeglin, B. C., Sauvé, C.-E. G., Thapa, I., Bastola, D., Chen, X. S., Smith, J. J., Singh, A. B., & Dhawan, P. (2021). A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients. Cells, 10(9), 2211. https://doi.org/10.3390/cells10092211